Cell MedX Corp. Financial Ratios — CMXC Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-73.05	-304.22	-4,321.85	-1,356.07	-444.13	-912.6	-768.43	-624.9	-861.63	-1,490.35	-684.64	-190.75
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	37.69	22.27	34.87	- -	- -	89.32	52.09	66.5	17.49	- -
EBITDA Margin (%)	- -	- -	- -	-2,193.83	-5,699.73	-17,641.64	- -	- -	-1,081.68	-10,058.46	-11,056.03	-16,207.75	- -
Operating Margin (%)	- -	- -	- -	-2,198.41	-5,756.09	-19,619.87	- -	- -	-1,083.6	-10,094.45	-11,074.91	-16,207.75	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	5,067.77	- -	- -	- -	- -	- -	-6,491.89
Pretax Margin (%)	- -	- -	- -	-2,421.56	-5,851.51	-20,087.56	- -	- -	-1,140.32	-13,469.92	-11,498.42	-17,923.32	- -
Profit Margin (%)	- -	- -	- -	-2,421.56	-5,851.51	-20,087.56	- -	- -	-1,140.32	-13,469.92	-11,498.42	-17,923.32	- -
Net Income to Common Margin (%)	- -	- -	- -	-2,421.56	-5,851.51	-20,087.56	- -	- -	-1,140.32	-13,469.92	-11,498.42	-17,923.32	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Total Debt	- -	- -	- -	- -	1	1	- -	1	1	- -	1	1	- -
ST Debt	- -	- -	- -	- -	1	1	- -	1	1	- -	1	1	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	-0.29	-0.46	-0.49	-0.08	-0.76	-0.48	-0.44	-0.92	-2.24	-1.17
Net Debt/EBITDA	1.49	0.87	0.06	-0.29	-0.44	-0.43	-0.07	-0.68	-0.44	-0.41	-0.88	-2.02	-1.01
Total Debt/EBIT	- -	- -	- -	-0.29	-0.45	-0.44	-0.08	-0.76	-0.48	-0.44	-0.92	-2.24	-1.17
Net Debt/EBIT	1.49	0.87	0.06	-0.29	-0.44	-0.39	-0.07	-0.68	-0.44	-0.41	-0.88	-2.02	-1.01
EBITDA to Interest Expense	- -	- -	- -	-150.48	-55.03	-21.09	-136.77	-40.05	-49.2	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	-154.96	-60.81	-23.21	-136.77	-40.16	-49.31	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	-150.8	-55.57	-23.45	-136.77	-40.08	-49.28	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	131.27	-307.57	-4,354.29	-2,328.97	-1,198.69	-1,519.7	-13,271.52	-3,627.85	-5,021.77	-17,032.81	-23,207.27	-9,770.36	-21,677.35
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	-40.03	-67.38	-46.29	-10.94	-28.87	-33.05	-19.17	-30.7	-41.96	-37.93
Total Debt/Capital (%)	- -	- -	- -	-33.77	-41.89	-13.8	-1.99	-8	-6.71	-3.51	-6.87	-11.01	-3.24
Total Debt/Total Assets (%)	- -	- -	- -	588.01	353.89	184.29	259.53	268.58	315.64	578.24	1,491.83	969.33	679.7
Net Debt to Equity	-219.31	587.74	5.89	-39.84	-65.42	-40.52	-10.18	-25.65	-30.08	-17.85	-29.49	-37.84	-32.68
Net Debt/Capital (%)	-319.77	24.54	2.25	-33.57	-40.19	-11.87	-1.85	-7.04	-6.07	-3.26	-6.58	-9.83	-2.78
EBITDA	- -	- -	- -	-1	-2	-1	-2	-1	-1	-1	-1	- -	- -
EBITDA-CapEx	- -	- -	- -	-1	-2	-1	-2	-1	-1	-1	-1	- -	- -
Operating Income (Loss)	- -	- -	- -	-1	-2	-1	-2	-1	-1	-1	-1	- -	- -

Liquidity (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Cash Ratio	1.84	0.85	0.06	- -	0.02	0.05	0.01	0.03	0.03	0.01	0.01	0.04	0.05
Current Ratio	1.84	0.85	0.06	0.03	0.04	0.07	0.04	0.1	0.09	0.03	0.02	0.04	0.05
Quick Ratio	1.84	0.85	0.06	- -	0.02	0.05	0.01	0.03	0.04	0.02	0.02	0.04	0.05
CFO/Avg Current Liab	- -	-0.98	-0.57	-0.84	-0.35	-0.48	-0.35	-0.2	-0.51	-0.34	-0.24	-0.12	-0.09
Common Equity/Total Assets	131.27	-307.57	-4,354.29	-2,328.97	-1,198.69	-1,519.7	-13,271.52	-3,627.85	-5,021.77	-17,032.81	-23,207.27	-9,770.36	-21,677.35
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	-40.03	-67.38	-46.29	-10.94	-28.87	-33.05	-19.17	-30.7	-41.96	-37.93
Total Debt/Capital (%)	- -	- -	- -	-33.77	-41.89	-13.8	-1.99	-8	-6.71	-3.51	-6.87	-11.01	-3.24
Total Debt/Total Assets (%)	- -	- -	- -	588.01	353.89	184.29	259.53	268.58	315.64	578.24	1,491.83	969.33	679.7
CFO/Total Liabilities	-149.83	-98.36	-45.28	-43.36	-25.07	-51.54	-40.17	-15.67	-55.13	-34.42	-21.98	-10.94	-16.72
CFO/CapEx	- -	- -	- -	-11.4	-1.93	-6.84	- -	-160.6	-375.9	-356.06	- -	- -	- -
Altman's Z-Score	-1.67	-12.26	-123.6	-114.02	-49.67	-40.43	-327.35	-73.79	-102.42	-318.94	-438.69	-179.61	-348.23

Working Capital (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	75.13	10.71	0.63	- -	- -	0.16	0.12	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	4.86	34.08	574.85	- -	- -	2,230.2	2,922.59	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	0.22	0.1	0.02	0.01	0.09	-0.01	-0.07	- -	0.01	- -
Accounts Payable Turnover Days	- -	- -	- -	1,639.15	3,542.34	19,938.77	72,273.05	3,886.39	-27,065.55	-5,028.55	78,499.43	68,123.43	- -
Cash Conversion Cycle	- -	- -	- -	-1,634.3	-3,508.26	-19,363.92	- -	- -	29,295.75	7,951.14	-78,499.43	-68,123.43	- -
Inventory to Cash Days	- -	- -	- -	-4.86	-34.08	-574.85	- -	- -	-2,230.2	-2,922.59	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Market Capitalization	- -	- -	2	4	1	1	- -	- -	2	1	- -	- -	7
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	1	1	- -	1	1	- -	1	1	- -
Enterprise Value	- -	- -	2	4	1	1	1	1	3	1	1	1	8
Total Capital	- -	- -	- -	-1	-2	-4	-6	-6	-7	-9	-9	-9	-10
Total Debt/Capital (%)	- -	- -	- -	-33.77	-41.89	-13.8	-1.99	-8	-6.71	-3.51	-6.87	-11.01	-3.24
Total Debt / EV	- -	- -	- -	0.06	0.66	0.45	0.21	0.66	0.19	0.22	0.61	0.98	0.04
EV/Sales	- -	- -	- -	100.94	39.41	191.76	- -	- -	27.47	203.71	166.7	370.88	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	2	4	1	1	- -	- -	2	1	- -	- -	7
Diluted Enterprise Value	- -	- -	2	4	1	1	1	1	3	1	1	1	8
EV per Share	- -	- -	0.78	2.08	0.7	0.49	0.2	0.26	0.74	0.35	0.24	0.24	0.7
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	- -	- -	-1	-2	-1	-2	-1	-1	-1	-1	- -	- -
TTM Operating Income	- -	- -	- -	-1	-2	-1	-2	-1	-1	-1	-1	- -	- -
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	-1	- -	- -	-1	-1	- -	- -	- -
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	-1	- -	- -	-1	-1	- -	- -	- -

Multiples (USD)

API Chat

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Price/Free Cash Flow	- -	- -	-164.86	-13.94	-2.55	-1.12	-1	-1.06	-2.36	-1.96	-0.93	-0.45	-49.66
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	2	4	1	1	1	1	3	1	1	1	8
Low Price	- -	- -	0.1	0.21	0.12	0.12	0.1	0.05	0.1	0.2	0.08	0.02	- -
EV/Sales	- -	- -	- -	100.94	39.41	191.76	- -	- -	27.47	203.71	166.7	370.88	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-95.46	-5.16	-1.43	-0.53	-0.42	-0.42	-1.3	-1.57	-1.1	-0.47	-15.15
Price/Earnings High	- -	- -	-200.79	-24.33	-5.65	-0.93	-0.73	-0.98	-5.51	-2.79	-1.91	-1.05	-257.64
Price/Earnings Low	- -	- -	-11.15	-0.42	-0.12	-0.24	-0.18	-0.16	-0.33	-0.86	-0.5	-0.18	-0.02
Price/Book Value	- -	- -	-30.83	-3.72	-0.16	-0.16	-0.08	-0.05	-0.27	-0.12	-0.04	-0.01	-0.72
Price/Book Value Average	- -	- -	-33.82	-4.91	-0.95	-0.15	-0.11	-0.06	-0.18	-0.16	-0.08	-0.02	-0.22
Price/Book Value High	- -	- -	-71.13	-23.15	-3.75	-0.26	-0.19	-0.13	-0.75	-0.29	-0.14	-0.05	-3.67
Price/Book Value Low	- -	- -	-3.95	-0.4	-0.08	-0.07	-0.05	-0.02	-0.05	-0.09	-0.04	-0.01	- -
Price/Tangible Book Value	- -	- -	-79.04	-5.89	-0.37	-0.61	-0.42	-0.18	-1.43	-0.7	-0.21	-0.05	-8.77
Price/Tangible Book Value Average	- -	- -	-86.72	-7.78	-2.17	-0.56	-0.61	-0.22	-0.94	-0.91	-0.38	-0.1	-2.61
Price/Tangible Book Value High	- -	- -	-182.4	-36.71	-8.56	-1	-1.05	-0.5	-3.96	-1.61	-0.66	-0.22	-44.42
Price/Tangible Book Value Low	- -	- -	-10.13	-0.63	-0.18	-0.25	-0.26	-0.08	-0.24	-0.5	-0.17	-0.04	- -
Price/Sales	- -	- -	- -	94.55	14.13	115.59	- -	- -	22.7	162.1	69.03	44.04	- -
Price/Sales Average	- -	- -	- -	124.88	83.83	106.14	- -	- -	14.88	211.47	126.16	83.44	- -
Price/Sales High	- -	- -	- -	589.1	330.72	187.66	- -	- -	62.88	376	219.51	188.33	- -
Price/Sales Low	- -	- -	- -	10.18	6.78	47.41	- -	- -	3.79	116.45	57.22	32.05	- -
Price/Cash Flow	- -	- -	-164.86	-12.72	-1.23	-0.95	-1	-1.06	-2.35	-1.96	-0.93	-0.45	-49.66
Price/Cash Flow Average	- -	- -	-180.87	-16.8	-7.27	-0.88	-1.45	-1.25	-1.54	-2.55	-1.7	-0.85	-14.8
Price/Cash Flow High	- -	- -	-380.45	-79.26	-28.68	-1.55	-2.51	-2.88	-6.51	-4.54	-2.95	-1.91	-251.61
Price/Cash Flow Low	- -	- -	-21.14	-1.37	-0.59	-0.39	-0.63	-0.48	-0.39	-1.41	-0.77	-0.33	-0.01
Price/Free Cash Flow Average	- -	- -	-180.87	-18.42	-15.11	-1.03	-1.45	-1.26	-1.54	-2.56	-1.7	-0.85	-14.8
Price/Free Cash Flow High	- -	- -	-380.45	-86.88	-59.62	-1.81	-2.51	-2.9	-6.53	-4.55	-2.95	-1.91	-251.61
Price/Free Cash Flow Low	- -	- -	-21.14	-1.5	-1.22	-0.46	-0.63	-0.48	-0.39	-1.41	-0.77	-0.33	-0.01
EV/Sales Average	- -	- -	- -	131.28	109.11	182.31	- -	- -	19.65	253.07	223.84	410.28	- -
EV/Sales High	- -	- -	- -	595.5	356	263.83	- -	- -	67.65	417.61	317.19	515.17	- -
EV/Sales Low	- -	- -	- -	16.58	32.06	123.58	- -	- -	8.57	158.05	154.9	358.89	- -
EV/EBITDA Average	1.49	0.87	-95.4	-5.98	-1.91	-1.03	-0.5	-1.25	-1.82	-2.52	-2.02	-2.53	-9.05
EV/EBITDA High	1.49	0.87	-200.72	-27.14	-6.25	-1.5	-0.81	-2	-6.25	-4.15	-2.87	-3.18	-137.8
EV/EBITDA Low	1.49	0.87	-11.09	-0.76	-0.56	-0.7	-0.26	-0.9	-0.79	-1.57	-1.4	-2.21	-1.01
EV/EBIT Average	1.49	0.87	-95.4	-5.97	-1.9	-0.93	-0.5	-1.25	-1.81	-2.51	-2.02	-2.53	-9.05
EV/EBIT High	1.49	0.87	-200.72	-27.09	-6.18	-1.34	-0.81	-2	-6.24	-4.14	-2.86	-3.18	-137.8
EV/EBIT Low	1.49	0.87	-11.09	-0.75	-0.56	-0.63	-0.26	-0.9	-0.79	-1.57	-1.4	-2.21	-1.01
Last Price	- -	- -	0.78	1.95	0.25	0.29	0.16	0.11	0.61	0.28	0.1	0.03	0.68
High Price	- -	- -	1.8	12.15	5.85	0.48	0.4	0.3	1.69	0.65	0.32	0.12	3.42
Enterprise Value Average	- -	- -	2	6	4	1	1	1	2	2	1	1	2
Enterprise Value High	- -	- -	4	25	13	2	1	1	6	3	2	1	37
Enterprise Value Low	- -	- -	- -	1	1	1	- -	1	1	1	1	1	- -

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Shares Outstanding	2	2	2	2	2	3	3	3	4	4	4	4	20
Diluted Weighted Avg Shares	2	2	2	2	2	2	3	3	4	4	4	4	11
Basic Weighted Avg Shares	2	2	2	2	2	2	3	3	4	4	4	4	11
Revenue per Share	- -	- -	- -	0.02	0.02	- -	- -	- -	0.03	- -	- -	- -	- -
EBITDA per Share	-0.01	-0.01	-0.01	-0.45	-1.01	-0.45	-0.54	-0.23	-0.29	-0.17	-0.16	-0.11	-0.03
Operating Income per Share	-0.01	-0.01	-0.01	-0.45	-1.02	-0.5	-0.54	-0.23	-0.29	-0.17	-0.16	-0.11	-0.03
Basic EPS, GAAP	-0.01	-0.01	-0.01	-0.5	-1.04	-0.51	-0.55	-0.31	-0.31	-0.23	-0.17	-0.12	-0.01
Basic EPS from Cont Ops	-0.01	-0.01	-0.01	-0.5	-1.04	-0.51	-0.55	-0.31	-0.31	-0.23	-0.17	-0.12	-0.01
Diluted EPS, GAAP	-0.01	-0.01	-0.01	-0.5	-1.04	-0.51	-0.55	-0.31	-0.31	-0.23	-0.17	-0.12	-0.01
Diluted EPS from Cont Ops	-0.01	-0.01	-0.01	-0.5	-1.04	-0.51	-0.55	-0.31	-0.31	-0.23	-0.17	-0.12	-0.01
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.01	-0.01	- -	-0.15	-0.2	-0.31	-0.16	-0.1	-0.26	-0.14	-0.11	-0.06	-0.01
Free Cash Flow per Basic Share	-0.01	-0.01	- -	-0.17	-0.31	-0.35	-0.16	-0.1	-0.26	-0.14	-0.11	-0.06	-0.01
Cash & Equivalents per Share	0.01	0.01	- -	- -	0.01	0.03	- -	0.02	0.01	0.01	0.01	0.02	- -
Book Value per Share	0.02	-0.02	-0.03	-0.52	-1.56	-1.82	-2.13	-2.34	-2.24	-2.27	-2.29	-2.41	-0.93
Tangible Book Value per Share	0.01	- -	-0.01	-0.33	-0.68	-0.48	-0.38	-0.6	-0.43	-0.4	-0.48	-0.57	-0.08

Cell MedX Corp.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)